
J&J sees tariff impact from exports to China more than global imports: CFO
Johnson & Johnson (JNJ) reported a beat on first quarter earnings Tuesday, even as concerns linger about how President Trump’s tariffs will impact its medical device business, as well as how a probe into pharmaceutical tariffs will impact its business. J&J reported first quarter revenue of $21.9 billion, beating Wall Street estimates by 1.4%. Adjusted…